Impact of dairy protein during limb immobilization and recovery on muscle size and protein synthesis; a randomized controlled trial

J Appl Physiol (1985). 2018 Mar 1;124(3):717-728. doi: 10.1152/japplphysiol.00803.2017. Epub 2017 Nov 9.

Abstract

Muscle disuse results in the loss of muscular strength and size, due to an imbalance between protein synthesis (MPS) and breakdown (MPB). Protein ingestion stimulates MPS, although it is not established if protein is able to attenuate muscle loss with immobilization (IM) or influence the recovery consisting of ambulatory movement followed by resistance training (RT). Thirty men (49.9 ± 0.6 yr) underwent 14 days of unilateral leg IM, 14 days of ambulatory recovery (AR), and a further six RT sessions over 14 days. Participants were randomized to consume an additional 20 g of dairy protein or placebo with a meal during the intervention. Isometric knee extension strength was reduced following IM (-24.7 ± 2.7%), partially recovered with AR (-8.6 ± 2.6%), and fully recovered after RT (-0.6 ± 3.4%), with no effect of supplementation. Thigh muscle cross-sectional area decreased with IM (-4.1 ± 0.5%), partially recovered with AR (-2.1 ± 0.5%), and increased above baseline with RT (+2.2 ± 0.5%), with no treatment effect. Myofibrillar MPS, measured using deuterated water, was unaltered by IM, with no effect of protein. During AR, MPS was increased only with protein supplementation. Protein supplementation did not attenuate the loss of muscle size and function with disuse or potentiate recovery but enhanced myofibrillar MPS during AR. NEW & NOTEWORTHY Twenty grams of daily protein supplementation does not attenuate the loss of muscle size and function induced by 2 wk of muscle disuse or potentiate recovery in middle-age men. Average mitochondrial but not myofibrillar muscle protein synthesis was attenuated during immobilization with no effect of supplementation. Protein supplementation increased myofibrillar protein synthesis during a 2-wk period of ambulatory recovery following disuse but without group differences in phenotype recovery.

Keywords: atrophy; deuterium; disuse; milk protein; resistance training.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Citrate (si)-Synthase / metabolism
  • Dietary Supplements
  • Exercise
  • Humans
  • Immobilization / adverse effects*
  • Male
  • Middle Aged
  • Milk Proteins / pharmacology
  • Milk Proteins / therapeutic use*
  • Muscle Proteins / biosynthesis
  • Muscle Proteins / metabolism
  • Muscle Strength / drug effects
  • Muscle, Skeletal / diagnostic imaging
  • Muscle, Skeletal / drug effects*
  • Muscle, Skeletal / metabolism
  • Muscular Atrophy / etiology
  • Muscular Atrophy / prevention & control*
  • SKP Cullin F-Box Protein Ligases / metabolism

Substances

  • Milk Proteins
  • Muscle Proteins
  • FBXO32 protein, human
  • SKP Cullin F-Box Protein Ligases
  • Citrate (si)-Synthase